All Sites It has been a couple of challenging years for drugmaker Hospira. FDA issued a Class I recall of Hospira- and Abbott-branded infusion pumps because of broken door assemblies, reports Qmed.com. It’s at least the sixth time since the start of 2013 that the company has been the subject of a Class I recall. The faulty assembly could result in serious death or injury because it could lead to overinfusion or delay of therapy. read more

Continue Reading:
Medtech Digest: Hospira recall; Apple’s deep dive into medical apps; Teleflex plans layoffs, plant closure